0001950047-23-000497.txt : 20230510
0001950047-23-000497.hdr.sgml : 20230510
20230510152330
ACCESSION NUMBER: 0001950047-23-000497
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230510
DATE AS OF CHANGE: 20230510
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 23905925
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Smith Brendan
CENTRAL INDEX KEY: 0001857492
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
144
1
primary_doc.xml
144
0001857492
XXXXXXXX
LIVE
0001674416
CRISPR THERAPEUTICS AG
001-37923
Baarerstrasse 14
Zug
V8
6300
41 (0)41 561 32 77
Brendan Smith
Officer
Common
Morgan Stanley Smith Barney LLC
1 New York Plaza
38th Floor
New York
NY
10004
9583
662402.83
78935098
05/10/2023
NASD
Common
05/10/2023
Stock Option Exercise
Issuer
N
9583
05/10/2023
Cash
Y
05/10/2023
/s/ Brendan Smith